Indian stock markets closed lower on October 28, 2026, after recovering part of a steep intraday decline. The Sensex fell 353 points to 73,246, while the Nifty 50 lost 51 points to finish at 22,699.

Key Takeaways

  • The Sensex had fallen nearly 1,000 points during the session, and the Nifty briefly slipped below 22,500.
  • More stocks advanced than declined on the National Stock Exchange, despite the benchmark losses.

Indian stock markets recover from early lows

The benchmarks ended in the red despite a strong debut for Jio Platforms, which became India’s second-most valuable listed company.

Vinod Nair, head of research at Geojit Investments, said a rise in crude oil prices and selling in information technology stocks weighed on sentiment. He cited buying at lower levels and resilience in banking, auto and pharmaceutical stocks among factors supporting the recovery.

Trading breadth and active shares

Of the 3,678 stocks traded on the National Stock Exchange, 1,931 advanced, 1,628 declined and 119 were unchanged.

Bharti Airtel was among the most active stocks by turnover, with ₹2,827 crore traded, followed by Piramal Pharma at ₹2,684 crore. Piramal Pharma also reached a 52-week high during the session.

Global markets and the Fed meeting

Investors were also watching the Federal Reserve’s October 27–28 policy meeting, with a press conference scheduled for October 28. The meeting’s outcome was still ahead at the time of the market update.

In US trading on Wednesday, Micron Technology rose 4.8% and SK hynix’s US-listed shares gained 10.6% after the South Korean chipmaker reported a sharp rise in quarterly profit. Europe’s STOXX index was down 0.25%.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.